Prospective trial with optical molecular imaging for percutaneous interventions in focal hepatic lesions.

ABSTRACT:

Purpose

To demonstrate the clinical translation of optical molecular imaging (OMI) for the localization of focal hepatic lesions during percutaneous hepatic interventions.

Materials and methods

Institutional review board approval was obtained for this prospective, single-center, HIPAA-compliant trial. Patients who were suspected of having hepatocellular carcinoma or liver metastases from colorectal cancer and were scheduled for percutaneous liver biopsy or thermal ablation were eligible for this study. Patients (n = 5) received 0.5 mg per kilogram of body weight of indocyanine green (ICG) intravenously 24 hours prior to their scheduled procedure in this study. Intraprocedurally, a handheld device composed of an endoscope that fits coaxially through a standard 17-gauge introd

SUBMITTER: Sheth RA 

PROVIDER: S-EPMC4407559 | biostudies-literature | 2015 Mar

REPOSITORIES: biostudies-literature